Yale Digital Medicine Symposium 2019

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Ethical Considerations, Digital Medicine Jennifer Miller, PhD| Yale School of Medicine Closing Remarks and Acknowledgements Michael Dempsey | Yale Center for Biomedical Innovation and Technology

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Digital Medicine and Drug Supply Chain: Marc Appel | Yale Entrepreneur – in – Residence Jon Lanznar | VP Client Services at Truveris David Light | CEO of Valisure

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Opening Remarks: Gregory Licholai, MD | Yale School of Management

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Data Outcomes and Digital Medicine: Harlan Krumholz, MD | Yale School of Medicine

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Digital Therapeutic Perspective Eddie Martucci, PhD | Ceo, Co-Founder, Akili Interactive Lynn Hamilton | Chief Operating Officer, Talkspace John Whang, MD | Head Cardiovascular & Metabolism, Johnson and Johnson Scooter Plowman, MD | Medical Director, Proteus Digital Health

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia. Artificial Intelligence and Digital Medicine: Walter de Brouwer, PhD | CEO at Doc.ai